---
category: news
title: "Predictive AI Biomarker for ADT Benefit in Prostate Cancer Identified"
excerpt: "New AI biomarker predicts the benefit of short-term androgen deprivation therapy (ADT) in men with predominantly intermediate-risk prostate cancer."
publishedDateTime: 2023-07-10T13:34:00Z
originalUrl: "https://healthitanalytics.com/news/predictive-ai-biomarker-for-adt-benefit-in-prostate-cancer-identified"
webUrl: "https://healthitanalytics.com/news/predictive-ai-biomarker-for-adt-benefit-in-prostate-cancer-identified"
type: article
quality: 39
heat: 39
published: false

provider:
  name: Analytics
  domain: healthitanalytics.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://healthitanalytics.com/images/site/article_headers/_normal/2022-03-18-GettyImages-1255213318.jpg"
    width: 690
    height: 400
    isCached: true

related:
  - title: "AI May Predict Benefit with Hormone Therapy Plus Radiotherapy in Prostate Cancer"
    excerpt: "Artificial intelligence was used to develop a predictive biomarker to identify patients with intermediate-risk prostate cancer who would benefit from adding androgen deprivation therapy to radiotherapy."
    publishedDateTime: 2023-07-06T13:00:00Z
    webUrl: "https://www.curetoday.com/view/ai-may-predict-benefit-with-hormone-therapy-plus-radiotherapy-in-prostate-cancer"
    type: article
    provider:
      name: Cure Today
      domain: curetoday.com
    quality: 29
  - title: "Novel AI Model Predicts ADT Benefit in Patients With Prostate Cancer"
    excerpt: "A predictive artificial intelligence (AI) biomarker of androgen deprivation therapy (ADT) benefit in prostate cancer was validated in a recent study published in NEJM Evidence."
    publishedDateTime: 2023-07-06T19:39:00Z
    webUrl: "https://www.ajmc.com/view/novel-ai-model-predicts-adt-benefit-in-patients-with-prostate-cancer"
    type: article
    provider:
      name: The American Journal of Managed Care
      domain: ajmc.com
    quality: 19

secured: "e09NJhk+XGLFeXZ6yHWzzdmEPfIEeVADAVelJIwEa2Kqmo24e3txnKFCq8d3pPz6RaOFRVCxz8h52Co8U/M1FUR8mNfDlR5spLUhjyAEvz4V+/il+2qkSs0c0/8LPEaHjISvSrLsRXtACppx4JxnxcMuW2qe2rmxZRi/ruMjPPMJS4ba9QsP75XpRyezKItYStPfYaiNSeFDBi753R0oW7/L3DVm4w3oYSkxWkvegRlsw3X8FU1XjnjoyJVat2IbXX4/tsXMR0wnAmO0NmIiUTkicmZ7VF8rZIjvT3mrYSuRh3O2PyPB4DAgnywsH5ckOYNG7zLix+ah9Tze8ITkbnJPfnQRgMsQplhhoe9nv7k=;uuZMBhOIJZCuzlEtXHuf0g=="
---

